C. Amadi, E. P. Odum, and B. M. Aleme, “Low endogenous testosterone level is associated with high-risk prostate-specific antigen level in men with prostate cancer disease”, Int Surg J, vol. 5, no. 5, pp. 1617–1621, Apr. 2018.